Study Overview
Dalbo et al. (2008) published a comprehensive safety review in the Journal of the International Society of Sports Nutrition systematically evaluating the evidence for and against common safety concerns about creatine monohydrate supplementation. The review examined claims regarding kidney function, liver function, dehydration, muscle cramping, gastrointestinal distress, and other purported adverse effects (RB et al., 2017) .
Key Findings
- No kidney damage: The review found no evidence that creatine supplementation causes kidney damage in healthy individuals. Elevated serum creatinine levels are expected (creatine is metabolised to creatinine) but do not indicate renal dysfunction
- No liver damage: No evidence supported the claim that creatine adversely affects liver function in healthy users
- Dehydration myth debunked: Contrary to popular belief, creatine does not cause dehydration. The review noted that creatine increases total body water, and some evidence suggests it may actually improve hydration status
- Muscle cramps not supported: No controlled study found creatine to increase muscle cramping. Some evidence suggested creatine users actually experienced fewer cramps during intense exercise
- GI distress is dose-dependent: Mild gastrointestinal discomfort can occur, particularly during high-dose loading phases. This is typically resolved by using lower doses or taking creatine with meals
- Weight gain is water, not fat: Reported weight gain is primarily intracellular water retention in muscle cells, not adipose tissue accumulation
Practical Implications
This review is essential reading for anyone concerned about creatine safety. It systematically addresses every major safety concern and finds them unsupported by the scientific evidence. For Malaysian consumers who may encounter fear-based marketing or misinformation about creatine on social media, this review provides a solid evidence base for confidence in creatine’s safety profile.
The key practical points for Malaysian users: take 3-5g of creatine monohydrate daily (skip loading if you experience GI discomfort), stay hydrated (especially important in Malaysia’s tropical climate), and inform your doctor you take creatine so that elevated creatinine on blood tests is not misinterpreted as kidney dysfunction (JR & M, 2000) .
Those with pre-existing kidney or liver disease should consult their doctor before starting creatine, as the safety evidence applies specifically to healthy individuals.
Study Limitations
- As a review article, the conclusions are only as strong as the underlying primary studies
- Most safety studies have been conducted in relatively young, healthy populations — long-term safety data in elderly or medically complex populations is more limited
- Industry funding of some primary studies may introduce bias
- Safety studies typically track outcomes for months to a few years — multi-decade safety data is limited (though no signals of harm have emerged from observational data)
Study Design and Methodology
Understanding how a study was designed helps assess the strength of its conclusions. Key methodological factors to evaluate include:
- Sample size — larger studies (n=50+) provide more reliable results than small studies (n=10-15). Small sample sizes increase the risk of false positives and limit the ability to detect moderate effect sizes
- Study duration — creatine research requires adequate duration for muscle saturation (minimum 4 weeks for maintenance dosing, 1 week for loading). Studies shorter than this may miss the full effect
- Blinding — double-blind, placebo-controlled designs (where neither researchers nor participants know who receives creatine) are the gold standard for minimising bias
- Population studied — results from trained athletes may not fully apply to untrained individuals, and vice versa. Age, sex, and dietary habits (particularly vegetarian status) also influence creatine response
- Outcome measures — direct measures (muscle biopsy, MRS imaging) are more informative than indirect proxies (blood markers, performance tests) for assessing creatine uptake and metabolism
Clinical Implications and Practical Relevance
This research contributes to our understanding of creatine in several practical ways:
For athletes and fitness enthusiasts: The findings support the use of creatine monohydrate as a safe, effective ergogenic aid. The standard dosing protocol of 3-5g daily remains well-supported by the cumulative evidence base including this study.
For healthcare professionals: Understanding the specific mechanisms and safety data from studies like this helps clinicians provide evidence-based guidance to patients who ask about creatine supplementation. The research consistently shows a favourable safety profile at recommended doses.
For the Malaysian context: While most creatine research is conducted in Western populations, the fundamental biochemistry (ATP-phosphocreatine system) is universal. Malaysian consumers can apply these findings with confidence, adjusting for local factors like tropical climate (increased hydration needs) and halal dietary requirements (synthetic creatine monohydrate is permissible).
How This Fits Into the Broader Evidence
No single study should be used to make definitive claims about creatine supplementation. Instead, this research should be viewed as one piece of a much larger evidence base:
- The ISSN Position Stand (2017) synthesises hundreds of studies into comprehensive recommendations
- Multiple systematic reviews and meta-analyses confirm creatine’s effects on strength, power, and lean mass
- Long-term safety data spanning up to 5 years shows no adverse effects at recommended doses
For a complete overview of the evidence, explore our Research Library which covers 60+ landmark creatine studies.
Sources & References
This page summarises Dalbo VJ, Roberts MD, Stout JR, Kerksick CM. Putting to rest the myth of creatine supplementation leading to muscle cramps and dehydration. British Journal of Sports Medicine. 2008;42(7):567-573.